Identifying Prostate Brachytherapy Seeds Using MRI

University Health Network, Toronto1 site in 1 country10 target enrollmentOctober 2012

ConditionsProstate Cancer Patients Who Have Brachytherapy Seed Implant

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Prostate Cancer Patients Who Have Brachytherapy Seed Implant
Sponsor: University Health Network, Toronto
Enrollment: 10
Locations: 1
Primary Endpoint: Determine if using the MR scan -(SWI) used to detect the implanted radioactive seeds will reduce registration errors
Status: Completed
Last Updated: 9 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

This study will look at the feasibility of using a type of Magnetic Resonance Imaging called Susceptibility Weighted Imaging (SWI) to detect your implanted radioactive seeds. Researchers hope that using SWI will eliminate the need to use CT imaging to detect your implanted radioactive seeds.

This study will also see if the MRI seed detection is as effective as current standard practice of seed detection (routine MRI and CT imaging). This technique would be beneficial for brachytherapy without the need to fuse the MRI and CT images, as is done currently.

Registry

clinicaltrials.gov

Start Date

October 2012

End Date

August 2016

Last Updated

9 years ago

Study Type

Interventional

Study Design

Single Group

Sex

Male

Investigators

Sponsor

University Health Network, Toronto

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•At least 18 years old
•Histologic diagnosis of adenocarcinoma of the prostate
•No contraindications for Pelvic body MRI
•Patients undergoing LDR brachytherapy at PMH and scheduled for post implant analysis with CT-MR (standard at PMH)
•Ability to provide written informed consent to participate in the study